TrypLE™ Select is a recombinant enzyme free of animal-derived components, allowing the dissociation of a wide range of adherent mammalian cells, including: CHO, HEK 293, A529, primary keratinocytes of human origin and cells of human origin.
TrypLE™ Select is a recombinant enzyme free of animal-derived components, allowing the dissociation of a wide range of adherent mammalian cells, including: CHO, HEK 293, A529, primary keratinocytes of human origin and embryonic stem cells. We offer a variety of TrypLE™ formulations for a range of cell culture applications.
Compared to trypsin and other dissociation reagents, the Gibco™ TrypLE™ Select solution is:
• Soft on cells: maintains cellular health for reproducible results
• Stable at room temperature: convenient to use
• Easy to use: acts as a substitute directly in existing protocols, without inactivation required
• Free animal origin (AOF): pure, consistent and effective
This TrypLE™ Select is amended as follows:
The formulation of trypLE™ solutions is available, although we keep the enzyme concentration confidential.
Easy on the cells
TrypLE™ Select, like trypsin, clives the peptide bonds on the carboxylic end sides of lysine and arginine. The exceptional purity of TrypLE™ Select nevertheless increases specificity by the action of a single enzyme. This reduces damage caused by the cleavage of several enzymes in trypsin and other extracts.
Stable at room temperature
TrypLE™ Select is stable at room temperature and ready to use. TrypLE™ Select cell dissociation reagents remain stable for 24 months at room temperature or 2 at 8°C, making storage and handling easier and more convenient.
TrypLE™ Select can be substituted for trypsin in existing protocols. In addition, dilution alone disables TrypLE™ Select, thus avoiding the need for trypsin inhibitors, such as SVF.
Without animal origin component (AOF)
Unlike porcine trypsin and other enzymes, TrypLE™ Select is free of animal-derived components and is formulated on dedicated equipment without animal-derived components.
Planned use of the product
For research or further manufacturing purposes. Do not use for diagnostic procedures. Customers using Gibco™ TrypLE™ Select in a manufacturing process, who must submit to FDA, can request a letter of authorization to refer to our DMF Master Drug File.
Quality system and BPFa compliant manufacturing
Gibco™ TrypLE™ Select is manufactured at a BPFa site located in Grand Island, New York, United States. The site is certified by FDA as a manufacturer of medical devices and is certified to ISO 13485.
The concentrated forms of TrypLE™ can be diluted aseptically to 1x using a balanced saline solution containing 1 mM of EDTA.